124 followers
@johnkriby1 @Covid19Crusher “ Consistent with higher number of infections, patients who received tocilizumab had higher mortality (35.2 vs. 19.3%; p = 0.020).“ IL-6 Inhibition in Critically Ill COVID-19 Patients Is Associated With Increased Secondary Infe